array(40) {
  [0]=>
  string(4) "8131"
  ["article_id"]=>
  string(4) "8131"
  [1]=>
  string(84) "Nestlé’s personalised vitamin service expands into Europe and worldwide   "
  ["article_title"]=>
  string(84) "Nestlé’s personalised vitamin service expands into Europe and worldwide   "
  [2]=>
  string(154) "Nestlà Health Scienceâs (NHSc) personalised vitamin subscription program, Persona is now available worldwide, with consumers from the UK, France and"
  ["short_description"]=>
  string(154) "Nestlà Health Scienceâs (NHSc) personalised vitamin subscription program, Persona is now available worldwide, with consumers from the UK, France and"
  [3]=>
  string(191) "Nestlà Health Scienceâs (NHSc) personalised vitamin subscription program, Persona is now available worldwide, with consumers from the UK, France and Germany among others set to benefit."
  ["description"]=>
  string(191) "Nestlà Health Scienceâs (NHSc) personalised vitamin subscription program, Persona is now available worldwide, with consumers from the UK, France and Germany among others set to benefit."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "35"
  ["rss_id"]=>
  string(2) "35"
  [14]=>
  string(161) "https://www.nutraingredients.com/Article/2020/03/09/Nestle-personalised-vitamin-service-available-in-EU-world?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(161) "https://www.nutraingredients.com/Article/2020/03/09/Nestle-personalised-vitamin-service-available-in-EU-world?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-03-09 14:00:00"
  ["add_date"]=>
  string(19) "2020-03-09 14:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:57"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8575"
  ["article_id"]=>
  string(4) "8575"
  [1]=>
  string(177) "Janssen Announces Results of Phase 3 Study Demonstrating the Safety and Efficacy of Long-Acting Injectable HIV Treatment Regimen of Rilpivirine And Cabotegravir through 96 Weeks"
  ["article_title"]=>
  string(177) "Janssen Announces Results of Phase 3 Study Demonstrating the Safety and Efficacy of Long-Acting Injectable HIV Treatment Regimen of Rilpivirine And Cabotegravir through 96 Weeks"
  [2]=>
  string(150) "CORK, IRELAND, March 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson presented new data from the global Phase "
  ["short_description"]=>
  string(150) "CORK, IRELAND, March 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson presented new data from the global Phase "
  [3]=>
  string(252) "CORK, IRELAND, March 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson presented new data from the global Phase 3 trial today for the novel, investigational, long-acting (LA), two-drug injectable regimen –..."
  ["description"]=>
  string(252) "CORK, IRELAND, March 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson presented new data from the global Phase 3 trial today for the novel, investigational, long-acting (LA), two-drug injectable regimen –..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/janssen-announces-results-phase-3-study-demonstrating-safety-efficacy-long-acting-injectable-hiv-18471.html?utm_source=ddc&utm_medium=rss&utm_campaign=Janssen+Announces+Results+of+Phase+3+Study+Demonstrating+the+Safety+and+Efficacy+of+Long-Acting+Injectable+HIV+"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/janssen-announces-results-phase-3-study-demonstrating-safety-efficacy-long-acting-injectable-hiv-18471.html?utm_source=ddc&utm_medium=rss&utm_campaign=Janssen+Announces+Results+of+Phase+3+Study+Demonstrating+the+Safety+and+Efficacy+of+Long-Acting+Injectable+HIV+"
  [15]=>
  string(19) "2020-03-09 09:03:48"
  ["add_date"]=>
  string(19) "2020-03-09 09:03:48"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:18:05"
  ["create_at"]=>
  string(19) "2020-03-31 11:18:05"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8576"
  ["article_id"]=>
  string(4) "8576"
  [1]=>
  string(191) "Janssen Announces 48-week Results of Phase 3b Study Demonstrating the Safety and Efficacy of Long-Acting Injectable HIV Treatment of Rilpivirine and Cabotegravir Administered Every Two Months"
  ["article_title"]=>
  string(191) "Janssen Announces 48-week Results of Phase 3b Study Demonstrating the Safety and Efficacy of Long-Acting Injectable HIV Treatment of Rilpivirine and Cabotegravir Administered Every Two Months"
  [2]=>
  string(150) "CORK, IRELAND, March 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson presented new data from its global Phase "
  ["short_description"]=>
  string(150) "CORK, IRELAND, March 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson presented new data from its global Phase "
  [3]=>
  string(245) "CORK, IRELAND, March 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson presented new data from its global Phase 3b trial today for the novel, investigational, long-acting (LA), two-drug injectable regimen..."
  ["description"]=>
  string(245) "CORK, IRELAND, March 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson presented new data from its global Phase 3b trial today for the novel, investigational, long-acting (LA), two-drug injectable regimen..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/janssen-announces-48-week-results-phase-3b-study-demonstrating-safety-efficacy-long-acting-18470.html?utm_source=ddc&utm_medium=rss&utm_campaign=Janssen+Announces+48-week+Results+of+Phase+3b+Study+Demonstrating+the+Safety+and+Efficacy+of+Long-Acting+Injectable+H"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/janssen-announces-48-week-results-phase-3b-study-demonstrating-safety-efficacy-long-acting-18470.html?utm_source=ddc&utm_medium=rss&utm_campaign=Janssen+Announces+48-week+Results+of+Phase+3b+Study+Demonstrating+the+Safety+and+Efficacy+of+Long-Acting+Injectable+H"
  [15]=>
  string(19) "2020-03-09 09:03:37"
  ["add_date"]=>
  string(19) "2020-03-09 09:03:37"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:18:05"
  ["create_at"]=>
  string(19) "2020-03-31 11:18:05"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8021"
  ["article_id"]=>
  string(4) "8021"
  [1]=>
  string(82) "FDA Approves Isturisa (osilodrostat) for the Treatment of Cushing’s Disease"
  ["article_title"]=>
  string(82) "FDA Approves Isturisa (osilodrostat) for the Treatment of Cushing’s Disease"
  [2]=>
  string(150) "March 06, 2020 -- The U.S. Food and Drug Administration today approved Isturisa (osilodrostat) oral tablets for adults with Cushing’s disease wh"
  ["short_description"]=>
  string(150) "March 06, 2020 -- The U.S. Food and Drug Administration today approved Isturisa (osilodrostat) oral tablets for adults with Cushing’s disease wh"
  [3]=>
  string(249) "March 06, 2020 -- The U.S. Food and Drug Administration today approved Isturisa (osilodrostat) oral tablets for adults with Cushing’s disease who either cannot undergo pituitary gland surgery or have undergone the surgery but still have the..."
  ["description"]=>
  string(249) "March 06, 2020 -- The U.S. Food and Drug Administration today approved Isturisa (osilodrostat) oral tablets for adults with Cushing’s disease who either cannot undergo pituitary gland surgery or have undergone the surgery but still have the..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "8"
  ["rss_id"]=>
  string(1) "8"
  [14]=>
  string(216) "https://www.drugs.com/newdrugs/fda-approves-isturisa-osilodrostat-cushing-s-5179.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Approves+Isturisa+%28osilodrostat%29+for+the+Treatment+of+Cushing%E2%80%99s+Disease"
  ["blog_url"]=>
  string(216) "https://www.drugs.com/newdrugs/fda-approves-isturisa-osilodrostat-cushing-s-5179.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Approves+Isturisa+%28osilodrostat%29+for+the+Treatment+of+Cushing%E2%80%99s+Disease"
  [15]=>
  string(19) "2020-03-09 06:03:37"
  ["add_date"]=>
  string(19) "2020-03-09 06:03:37"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:18:17"
  ["create_at"]=>
  string(19) "2020-03-11 16:18:17"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8161"
  ["article_id"]=>
  string(4) "8161"
  [1]=>
  string(65) "Handheld 3D Printer Could Be Game Changer in Burn and Trauma Care"
  ["article_title"]=>
  string(65) "Handheld 3D Printer Could Be Game Changer in Burn and Trauma Care"
  [2]=>
  string(153) "&#nlA new handheld 3D printer that looks sort of like a packing tape dispenser can apply sheets of skin to cover large burn wounds, and its â€"
  ["short_description"]=>
  string(153) "&#nlA new handheld 3D printer that looks sort of like a packing tape dispenser can apply sheets of skin to cover large burn wounds, and its â€"
  [3]=>
  string(4605) "&#nl
A new handheld 3D printer that looks sort of like a packing tape dispenser can apply sheets of skin to cover large burn wounds, and its “bio ink” can accelerate the healing process, according to researchers from University of Toronto Engineering and Sunnybrook Health Sciences Centre in Toronto.
&#nl&#nl&#nl
The handheld 3D printer can apply sheets of skin to cover large burn wounds. It could be seen in a clinical setting within the next five years, according to researchers. Image courtesy Daria Perevezentsev/University of Toronto Engineering News.
The device covers wounds with a uniform sheet of biomaterial, stripe by stripe. The bio ink dispensed by the roller is composed of mesenchymal stroma cells (MSCs) — stem cells that differentiate into specialized cell types depending on their environment. In this case, the MSC material promotes skin regeneration and reduces scarring. Successful in vivo trials on full-thickness wounds are reported in the journal Biofabrication.
&#nl
The paper is a major step forward for the team of researchers, which unveiled the first prototype of the skin printer in 2018, according to an article on the University of Toronto Engineering News website. The device was believed to be the first of its kind to form tissue in situ, depositing and setting in place in two minutes or less. “Previously, we proved that we could deposit cells onto a burn, but there wasn’t any proof that there were any wound-healing benefits. Now we’ve demonstrated that,” said Axel Guenther, professor of mechanical and industrial engineering, who is supervising the project led by Richard Cheng, PhD candidate at the Institute of Biomaterials & Biomedical Engineering. They are working in close collaboration with Dr. Marc Jeschke, director of the Ross Tilley Burn Centre, and his team at Sunnybrook Hospital.
&#nl
The current method of care for burns is autologous skin grafting, which requires transplantation of healthy skin from other parts of the body onto the wound. But large, full-body burns pose a greater challenge. Full-thickness burns are characterized by the destruction of both the outermost and innermost layers of the skin; these burns often cover a significant portion of the body. “With big burns, you don’t have sufficient healthy skin available, which could lead to patient deaths,” Jeschke told Liz Do, who authored the article on the university's website.
&#nl
Since 2018, the handheld 3D printer has gone through 10 redesigns, as the team moves toward a design they envision surgeons using in an operating room. The current prototype includes a single-use microfluidic printhead to ensure sterilization, and a soft wheel that follows the track of the printhead, allowing for better control for wider wounds.
&#nl
Next, Cheng says that they ultimately want to “further reduce the amount of scarring, on top of helping with wound healing. Our main focus moving forward will be on the in vivo side.”
&#nl
Jeschke told Do that he believes the handheld skin printer could be seen in a clinical setting within the next five years. “Once it’s used in an operating room, I think this printer will be a game changer in saving lives. With a device like this, it could change the entirety of how we practice burn and trauma care.”
&#nl
"
  ["description"]=>
  string(4605) "&#nl
A new handheld 3D printer that looks sort of like a packing tape dispenser can apply sheets of skin to cover large burn wounds, and its “bio ink” can accelerate the healing process, according to researchers from University of Toronto Engineering and Sunnybrook Health Sciences Centre in Toronto.
&#nl&#nl&#nl
The handheld 3D printer can apply sheets of skin to cover large burn wounds. It could be seen in a clinical setting within the next five years, according to researchers. Image courtesy Daria Perevezentsev/University of Toronto Engineering News.
The device covers wounds with a uniform sheet of biomaterial, stripe by stripe. The bio ink dispensed by the roller is composed of mesenchymal stroma cells (MSCs) — stem cells that differentiate into specialized cell types depending on their environment. In this case, the MSC material promotes skin regeneration and reduces scarring. Successful in vivo trials on full-thickness wounds are reported in the journal Biofabrication.
&#nl
The paper is a major step forward for the team of researchers, which unveiled the first prototype of the skin printer in 2018, according to an article on the University of Toronto Engineering News website. The device was believed to be the first of its kind to form tissue in situ, depositing and setting in place in two minutes or less. “Previously, we proved that we could deposit cells onto a burn, but there wasn’t any proof that there were any wound-healing benefits. Now we’ve demonstrated that,” said Axel Guenther, professor of mechanical and industrial engineering, who is supervising the project led by Richard Cheng, PhD candidate at the Institute of Biomaterials & Biomedical Engineering. They are working in close collaboration with Dr. Marc Jeschke, director of the Ross Tilley Burn Centre, and his team at Sunnybrook Hospital.
&#nl
The current method of care for burns is autologous skin grafting, which requires transplantation of healthy skin from other parts of the body onto the wound. But large, full-body burns pose a greater challenge. Full-thickness burns are characterized by the destruction of both the outermost and innermost layers of the skin; these burns often cover a significant portion of the body. “With big burns, you don’t have sufficient healthy skin available, which could lead to patient deaths,” Jeschke told Liz Do, who authored the article on the university's website.
&#nl
Since 2018, the handheld 3D printer has gone through 10 redesigns, as the team moves toward a design they envision surgeons using in an operating room. The current prototype includes a single-use microfluidic printhead to ensure sterilization, and a soft wheel that follows the track of the printhead, allowing for better control for wider wounds.
&#nl
Next, Cheng says that they ultimately want to “further reduce the amount of scarring, on top of helping with wound healing. Our main focus moving forward will be on the in vivo side.”
&#nl
Jeschke told Do that he believes the handheld skin printer could be seen in a clinical setting within the next five years. “Once it’s used in an operating room, I think this printer will be a game changer in saving lives. With a device like this, it could change the entirety of how we practice burn and trauma care.”
&#nl
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "40"
  ["rss_id"]=>
  string(2) "40"
  [14]=>
  string(89) "https://www.mddionline.com/handheld-3d-printer-could-be-game-changer-burn-and-trauma-care"
  ["blog_url"]=>
  string(89) "https://www.mddionline.com/handheld-3d-printer-could-be-game-changer-burn-and-trauma-care"
  [15]=>
  string(19) "2020-03-09 03:00:01"
  ["add_date"]=>
  string(19) "2020-03-09 03:00:01"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:24:03"
  ["create_at"]=>
  string(19) "2020-03-11 16:24:03"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8103"
  ["article_id"]=>
  string(4) "8103"
  [1]=>
  string(59) "Low blood pressure linked to high mortality in older adults"
  ["article_title"]=>
  string(59) "Low blood pressure linked to high mortality in older adults"
  [2]=>
  string(150) "A large-scale study analyzed 415,980 electronic medical records of older adults in England. People aged 75 or over with low blood pressure (below 130/"
  ["short_description"]=>
  string(150) "A large-scale study analyzed 415,980 electronic medical records of older adults in England. People aged 75 or over with low blood pressure (below 130/"
  [3]=>
  string(377) "A large-scale study analyzed 415,980 electronic medical records of older adults in England. People aged 75 or over with low blood pressure (below 130/80) had increased mortality rates in the follow-up, compared to those with normal blood pressure. This was especially pronounced in 'frail' individuals, who had 62% increased risk of death during the 10-year follow-up. "
  ["description"]=>
  string(377) "A large-scale study analyzed 415,980 electronic medical records of older adults in England. People aged 75 or over with low blood pressure (below 130/80) had increased mortality rates in the follow-up, compared to those with normal blood pressure. This was especially pronounced in 'frail' individuals, who had 62% increased risk of death during the 10-year follow-up. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "29"
  ["rss_id"]=>
  string(2) "29"
  [14]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200307170735.htm"
  ["blog_url"]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200307170735.htm"
  [15]=>
  string(19) "2020-03-08 06:07:35"
  ["add_date"]=>
  string(19) "2020-03-08 06:07:35"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:52"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:52"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "7994"
  ["article_id"]=>
  string(4) "7994"
  [1]=>
  string(102) "Nearly Half of 46 California Cruise Ship Passengers Tested Have Coronavirus, as U.S. Cases Surpass 300"
  ["article_title"]=>
  string(102) "Nearly Half of 46 California Cruise Ship Passengers Tested Have Coronavirus, as U.S. Cases Surpass 300"
  [2]=>
  string(150) "SATURDAY, March 7, 2020 -- Nearly half of the 46 passengers tested aboard a cruise ship anchored off the California coast have the new coronavirus, Vi"
  ["short_description"]=>
  string(150) "SATURDAY, March 7, 2020 -- Nearly half of the 46 passengers tested aboard a cruise ship anchored off the California coast have the new coronavirus, Vi"
  [3]=>
  string(249) "SATURDAY, March 7, 2020 -- Nearly half of the 46 passengers tested aboard a cruise ship anchored off the California coast have the new coronavirus, Vice President Mike Pence announced Friday, as the total number of U.S. cases eclipsed 300 and the..."
  ["description"]=>
  string(249) "SATURDAY, March 7, 2020 -- Nearly half of the 46 passengers tested aboard a cruise ship anchored off the California coast have the new coronavirus, Vice President Mike Pence announced Friday, as the total number of U.S. cases eclipsed 300 and the..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(275) "https://www.drugs.com/news/nearly-46-california-cruise-ship-passengers-tested-have-coronavirus-u-s-cases-surpass-300-88796.html?utm_source=ddc&utm_medium=rss&utm_campaign=Nearly+Half+of+46+California+Cruise+Ship+Passengers+Tested+Have+Coronavirus%2C+as+U.S.+Cases+Surpass+300"
  ["blog_url"]=>
  string(275) "https://www.drugs.com/news/nearly-46-california-cruise-ship-passengers-tested-have-coronavirus-u-s-cases-surpass-300-88796.html?utm_source=ddc&utm_medium=rss&utm_campaign=Nearly+Half+of+46+California+Cruise+Ship+Passengers+Tested+Have+Coronavirus%2C+as+U.S.+Cases+Surpass+300"
  [15]=>
  string(19) "2020-03-07 20:03:01"
  ["add_date"]=>
  string(19) "2020-03-07 20:03:01"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:18:16"
  ["create_at"]=>
  string(19) "2020-03-11 16:18:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "7995"
  ["article_id"]=>
  string(4) "7995"
  [1]=>
  string(41) "Preventing COVID-19 Spread in Communities"
  ["article_title"]=>
  string(41) "Preventing COVID-19 Spread in Communities"
  [2]=>
  string(150) "Protect yourself and your community from getting and spreading respiratory illnesses like coronavirus disease 2019. Everyone has a role to play i"
  ["short_description"]=>
  string(150) "Protect yourself and your community from getting and spreading respiratory illnesses like coronavirus disease 2019. Everyone has a role to play i"
  [3]=>
  string(246) "Protect yourself and your community from getting and spreading respiratory illnesses like coronavirus disease 2019. Everyone has a role to play in getting ready and staying healthy.&#nlAmericans should be prepared for the possibility of a..."
  ["description"]=>
  string(246) "Protect yourself and your community from getting and spreading respiratory illnesses like coronavirus disease 2019. Everyone has a role to play in getting ready and staying healthy.&#nlAmericans should be prepared for the possibility of a..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(161) "https://www.drugs.com/news/preventing-covid-19-spread-communities-88794.html?utm_source=ddc&utm_medium=rss&utm_campaign=Preventing+COVID-19+Spread+in+Communities"
  ["blog_url"]=>
  string(161) "https://www.drugs.com/news/preventing-covid-19-spread-communities-88794.html?utm_source=ddc&utm_medium=rss&utm_campaign=Preventing+COVID-19+Spread+in+Communities"
  [15]=>
  string(19) "2020-03-07 09:03:33"
  ["add_date"]=>
  string(19) "2020-03-07 09:03:33"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:18:16"
  ["create_at"]=>
  string(19) "2020-03-11 16:18:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8162"
  ["article_id"]=>
  string(4) "8162"
  [1]=>
  string(58) "SXSW is Latest to Be Canceled Because of Coronavirus Fears"
  ["article_title"]=>
  string(58) "SXSW is Latest to Be Canceled Because of Coronavirus Fears"
  [2]=>
  string(153) "&#nlSouth by Southwest (SXSW) joins the list of conferences canceled due to concerns of the coronavirus pandemic. The event, which is a music, tech and f"
  ["short_description"]=>
  string(153) "&#nlSouth by Southwest (SXSW) joins the list of conferences canceled due to concerns of the coronavirus pandemic. The event, which is a music, tech and f"
  [3]=>
  string(2023) "&#nl
South by Southwest (SXSW) joins the list of conferences canceled due to concerns of the coronavirus pandemic. The event, which is a music, tech and film festival was slated to be held in Austin, TX from March 13 to March 22.
&#nl
In a statement on its website SXSW organizers said, “We are devastated to share this news with you. “The show must go on” is in our DNA, and this is the first time in 34 years that the March event will not take place. We are now working through the ramifications of this unprecedented situation.”
&#nl
Organizers said they were exploring options to reschedule the event and are working to provide a virtual SXSW online experience as soon as possible for 2020 participants.
&#nl
Initially, there were plans to continue with the conference – even though big-name companies like Twitter, Facebook, Apple, and Intel announced they were pulling out. But as coronavirus fears seem to grow the odds for the conference happening became slimmer.
&#nl
SXSW has become a hotspot for the newest and latest healthcare technology. In the past MD+DI has reported on the must-see startups to see at the conference.
&#nl
The move comes shortly after Healthcare Information and Management Systems Society (HIMSS), another popular tech conference was canceled. This marks the first time in 58 years that HIMSS won’t be held. It was scheduled to begin Monday.
"
  ["description"]=>
  string(2023) "&#nl
South by Southwest (SXSW) joins the list of conferences canceled due to concerns of the coronavirus pandemic. The event, which is a music, tech and film festival was slated to be held in Austin, TX from March 13 to March 22.
&#nl
In a statement on its website SXSW organizers said, “We are devastated to share this news with you. “The show must go on” is in our DNA, and this is the first time in 34 years that the March event will not take place. We are now working through the ramifications of this unprecedented situation.”
&#nl
Organizers said they were exploring options to reschedule the event and are working to provide a virtual SXSW online experience as soon as possible for 2020 participants.
&#nl
Initially, there were plans to continue with the conference – even though big-name companies like Twitter, Facebook, Apple, and Intel announced they were pulling out. But as coronavirus fears seem to grow the odds for the conference happening became slimmer.
&#nl
SXSW has become a hotspot for the newest and latest healthcare technology. In the past MD+DI has reported on the must-see startups to see at the conference.
&#nl
The move comes shortly after Healthcare Information and Management Systems Society (HIMSS), another popular tech conference was canceled. This marks the first time in 58 years that HIMSS won’t be held. It was scheduled to begin Monday.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "40"
  ["rss_id"]=>
  string(2) "40"
  [14]=>
  string(76) "https://www.mddionline.com/sxsw-latest-be-canceled-because-coronavirus-fears"
  ["blog_url"]=>
  string(76) "https://www.mddionline.com/sxsw-latest-be-canceled-because-coronavirus-fears"
  [15]=>
  string(19) "2020-03-07 08:09:24"
  ["add_date"]=>
  string(19) "2020-03-07 08:09:24"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:24:03"
  ["create_at"]=>
  string(19) "2020-03-11 16:24:03"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8046"
  ["article_id"]=>
  string(4) "8046"
  [1]=>
  string(76) "Test Topical Skin Products for Risk of Contact Dermatitis, FDA Guidance Says"
  ["article_title"]=>
  string(76) "Test Topical Skin Products for Risk of Contact Dermatitis, FDA Guidance Says"
  [2]=>
  string(153) "&#nl        Clinical trials of drug products intended for topical application should assess the risk of contact dermatitis, a new FDA draft guidance says"
  ["short_description"]=>
  string(153) "&#nl        Clinical trials of drug products intended for topical application should assess the risk of contact dermatitis, a new FDA draft guidance says"
  [3]=>
  string(164) "&#nl        Clinical trials of drug products intended for topical application should assess the risk of contact dermatitis, a new FDA draft guidance says.&#nl      "
  ["description"]=>
  string(164) "&#nl        Clinical trials of drug products intended for topical application should assess the risk of contact dermatitis, a new FDA draft guidance says.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(115) "https://www.fdanews.com/articles/196165-test-topical-skin-products-for-risk-of-contact-dermatitis-fda-guidance-says"
  ["blog_url"]=>
  string(115) "https://www.fdanews.com/articles/196165-test-topical-skin-products-for-risk-of-contact-dermatitis-fda-guidance-says"
  [15]=>
  string(19) "2020-03-07 07:14:07"
  ["add_date"]=>
  string(19) "2020-03-07 07:14:07"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:18:24"
  ["create_at"]=>
  string(19) "2020-03-11 16:18:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8047"
  ["article_id"]=>
  string(4) "8047"
  [1]=>
  string(64) "Indian Government Says Its API Supply is Secure for Three Months"
  ["article_title"]=>
  string(64) "Indian Government Says Its API Supply is Secure for Three Months"
  [2]=>
  string(158) "&#nl        India’s pharmaceutical agency reported last week that the country has enough active pharmaceutical ingredients to fuel its manufacturing op"
  ["short_description"]=>
  string(158) "&#nl        India’s pharmaceutical agency reported last week that the country has enough active pharmaceutical ingredients to fuel its manufacturing op"
  [3]=>
  string(349) "&#nl        India’s pharmaceutical agency reported last week that the country has enough active pharmaceutical ingredients to fuel its manufacturing operations for three months. But the rest of the world may not be as fortunate, with some APIs from the two largest global suppliers — China and India — now interrupted.&#nl      "
  ["description"]=>
  string(349) "&#nl        India’s pharmaceutical agency reported last week that the country has enough active pharmaceutical ingredients to fuel its manufacturing operations for three months. But the rest of the world may not be as fortunate, with some APIs from the two largest global suppliers — China and India — now interrupted.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(104) "https://www.fdanews.com/articles/196163-indian-government-says-its-api-supply-is-secure-for-three-months"
  ["blog_url"]=>
  string(104) "https://www.fdanews.com/articles/196163-indian-government-says-its-api-supply-is-secure-for-three-months"
  [15]=>
  string(19) "2020-03-07 07:12:50"
  ["add_date"]=>
  string(19) "2020-03-07 07:12:50"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:18:24"
  ["create_at"]=>
  string(19) "2020-03-11 16:18:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8144"
  ["article_id"]=>
  string(4) "8144"
  [1]=>
  string(69) "Senti Biosciences Appoints Jose Iglesias as Its Chief Medical Officer"
  ["article_title"]=>
  string(69) "Senti Biosciences Appoints Jose Iglesias as Its Chief Medical Officer"
  [2]=>
  string(150) "Senti Biosciences named Jose Iglesias as its chief medical officer, tasked with overseeing the development of its cell and gene therapy product candid"
  ["short_description"]=>
  string(150) "Senti Biosciences named Jose Iglesias as its chief medical officer, tasked with overseeing the development of its cell and gene therapy product candid"
  [3]=>
  string(431) "Senti Biosciences named Jose Iglesias as its chief medical officer, tasked with overseeing the development of its cell and gene therapy product candidates for the treatment of solid and liquid tumors. Iglesias’s previous experience includes CMO and clinical development leadership roles at companies including Boston Biomedical, Apobiologix, Biothera Pharmaceuticals, Bionomics, Celgene, Abraxis BioScience, and Eli […]"
  ["description"]=>
  string(431) "Senti Biosciences named Jose Iglesias as its chief medical officer, tasked with overseeing the development of its cell and gene therapy product candidates for the treatment of solid and liquid tumors. Iglesias’s previous experience includes CMO and clinical development leadership roles at companies including Boston Biomedical, Apobiologix, Biothera Pharmaceuticals, Bionomics, Celgene, Abraxis BioScience, and Eli […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(115) "https://xconomy.com/san-francisco/2020/03/06/senti-biosciences-appoints-jose-iglesias-as-its-chief-medical-officer/"
  ["blog_url"]=>
  string(115) "https://xconomy.com/san-francisco/2020/03/06/senti-biosciences-appoints-jose-iglesias-as-its-chief-medical-officer/"
  [15]=>
  string(19) "2020-03-07 06:41:48"
  ["add_date"]=>
  string(19) "2020-03-07 06:41:48"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:57"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}